New flu vaccine shows promise in large trial

NCT ID NCT05569239

Ongoing ⭐️ VACCINE ⭐️ Sponsor: Osivax Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 24 times

Summary

This study tests a single shot of an experimental flu vaccine called OVX836 in about 2,850 healthy adults aged 18 to 59. The goal is to see if it prevents flu better than a placebo and to check its safety. Participants are socially active people who are likely to be exposed to the flu virus.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

FI-14

Kokkola, Finland
Site BE-01

Ghent, Belgium
Site BE-02

Antwerp, Belgium
Site BE-03

Antwerp, Belgium
Site BE-04

Mechelen, Belgium
Site DE-16

München, Germany
Site FI-08

Helsinki, Finland
Site FI-09

Tampere, Finland
Site FI-10

Turku, Finland
Site FI-11

Oulu, Finland
Site FI-12

Espoo, Finland
Site FI-13

Jarvenpaa, Finland
Site FI-15

Seinäjoki, Finland
Site FR-05

Lyon, France
Site FR-06

Rennes, France
Site FR-07

Paris, France

Conditions

Explore the condition pages connected to this study.

INFLUENZA